Department of Functional Neurology and Epileptology, Hospices Civils de Lyon, Lyon, France; Lyon's Research Neuroscience Center, Institut National de la Santé et de la Recherche Médicale U1028, Centre National de la Recherche Scientifique 5292, Lyon, France; Department of Clinical Neurosciences, Centre Hospitalio-Universitaire Vaudois, Lausanne, Switzerland.
Clinical Neurosciences, UCL Institute of Child Health, Great Ormond Street Hospital for Children NHS Trust, London, UK, and Young Epilepsy, Surrey, UK; Young Epilepsy, Surrey, UK.
Lancet Neurol. 2014 Nov;13(11):1114-1126. doi: 10.1016/S1474-4422(14)70156-5.
Epilepsy surgery is the most effective way to control seizures in patients with drug-resistant focal epilepsy, often leading to improvements in cognition, behaviour, and quality of life. Risks of serious adverse events and deterioration of clinical status can be minimised in carefully selected patients. Accordingly, guidelines recommend earlier and more systematic assessment of patients' eligibility for surgery than is seen at present. The effectiveness of surgical treatment depends on epilepsy type, underlying pathology, and accurate localisation of the epileptogenic brain region by various clinical, neuroimaging, and neurophysiological investigations. Substantial progress has been made in the methods of presurgical assessment, particularly in patients with normal features on MRI, but evidence is scarce for the indication and effect of most presurgical investigations, with no biomarker precisely delineating the epileptogenic zone. A priority for the development of epilepsy surgery is the generation of high-level evidence to promote the harmonisation and dissemination of best practices.
癫痫手术是控制耐药性局灶性癫痫患者癫痫发作的最有效方法,通常可改善认知、行为和生活质量。在精心挑选的患者中,可以将严重不良事件和临床状况恶化的风险降至最低。因此,指南建议比目前更早且更系统地评估患者的手术资格。手术治疗的效果取决于癫痫类型、潜在病理以及通过各种临床、神经影像学和神经生理学检查对致痫脑区的准确定位。术前评估方法取得了重大进展,尤其是在 MRI 上无明显特征的患者,但大多数术前检查的适应证和效果证据很少,没有生物标志物能精确定位致痫区。制定癫痫手术的优先事项是生成高级别的证据,以促进最佳实践的协调和传播。